Detalles de la búsqueda
1.
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
N Engl J Med
; 389(22): 2039-2051, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870976
2.
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.
Cancer
; 125(24): 4435-4441, 2019 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31503332
3.
Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial.
Invest New Drugs
; 36(3): 476-486, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29177975
4.
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.
Gynecol Oncol
; 146(3): 531-537, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28651804
5.
Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non-Small Cell Lung Cancer.
Clin Pharmacol Ther
; 115(3): 468-477, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776107
6.
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.
Lung Cancer
; 178: 166-171, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868177
7.
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial.
Nat Med
; 29(10): 2577-2585, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37710001
8.
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 25(2): 219-228, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34257408
9.
JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies.
JTO Clin Res Rep
; 2(2): 100103, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589981
10.
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.
J Clin Oncol
; 39(30): 3391-3402, 2021 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339292
11.
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC.
Cancer Discov
; 10(8): 1194-1209, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414908
12.
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
J Clin Oncol
; 34(8): 786-93, 2016 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26371143
Resultados
1 -
12
de 12
1
Próxima >
>>